Wealth Enhancement Advisory Services, LLC Coherus Bio Sciences, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 34,275 shares of CHRS stock, worth $61,352. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,275
Previous 33,249
3.09%
Holding current value
$61,352
Previous $26,000
3.85%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CHRS
# of Institutions
122Shares Held
57.9MCall Options Held
89.3KPut Options Held
31K-
Black Rock Inc. New York, NY11.8MShares$21 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$18.9 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA5.1MShares$9.12 Million0.22% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$5.43 Million0.09% of portfolio
-
Geode Capital Management, LLC Boston, MA2.68MShares$4.79 Million0.0% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $139M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...